More about OXON

OXON, the Oxford medical cannabis company, represents pioneering cannabinoid research, innovation and quality assurance. OXON has developed market leading proprietary formulations under its exclusive partnership with Oxford Antibiotic Group and is developing research with leading academic institutions internationally.
Research and product development conducted by Equinox and its partners serves as the bedrock for the OXON range of cannabis products, which are designed to offer dosing precision, discretion and ease of use.

The Oxford Antibiotic Group is an innovative drug discovery and development company that brings together Austrian drug development expertise with Oxford’s excellence in Chemistry and Life Sciences.

Our mission is to find a solution for the unmet medical need in bacterial resistance, and to save life with new antibacterial therapies. Oxford Antibiotic works with Equinox International on exclusive cannabis whole plant formulations. 

Please visit for more information.

Close (esc)

Sign up to the OXON Newsletter

Receive regular updates, offers and information on the latest research and development.

Age verification

By clicking enter you are verifying that you are aged 18 years or older.

Shopping Cart

Your cart is currently empty.
Shop now